These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 20921437)

  • 21. Pacemaker and internal cardioverter defibrillator lead extraction: a safe and effective surgical approach.
    Kratz JM; Toole JM
    Ann Thorac Surg; 2010 Nov; 90(5):1411-7. PubMed ID: 20971231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
    Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
    J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.
    Alter P; Waldhans S; Plachta E; Moosdorf R; Grimm W
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):926-32. PubMed ID: 16176531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the transvenous extraction of cardioverter-defibrillator leads more hazardous than that of pacemaker leads?
    Małecka B; Kutarski A; Grabowski M
    Kardiol Pol; 2010 Aug; 68(8):884-90. PubMed ID: 20730717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database.
    Lee DS; Krahn AD; Healey JS; Birnie D; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    J Am Coll Cardiol; 2010 Feb; 55(8):774-82. PubMed ID: 20170816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram.
    Grammes JA; Schulze CM; Al-Bataineh M; Yesenosky GA; Saari CS; Vrabel MJ; Horrow J; Chowdhury M; Fontaine JM; Kutalek SP
    J Am Coll Cardiol; 2010 Mar; 55(9):886-94. PubMed ID: 20185039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).
    Greenspon AJ; Prutkin JM; Sohail MR; Vikram HR; Baddour LM; Danik SB; Peacock J; Falces C; Miro JM; Blank E; Naber C; Carrillo RG; Tseng CH; Uslan DZ
    J Am Coll Cardiol; 2012 Feb; 59(7):681-7. PubMed ID: 22322085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 15-year experience with permanent pacemaker and defibrillator lead and patch extractions.
    Rusanov A; Spotnitz HM
    Ann Thorac Surg; 2010 Jan; 89(1):44-50. PubMed ID: 20103204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
    de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is antiarrhythmia device implantation safe under dual antiplatelet therapy?
    Dreger H; Grohmann A; Bondke H; Gast B; Baumann G; Melzer C
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):394-9. PubMed ID: 20025706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillator: beyond efficacy.
    Timóteo AT; Adragão P; Morgado F; Abecassis M; Neves JP; Cavaco D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 2001 Nov; 20(11):1071-85. PubMed ID: 11826698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage of exposed implantable cardiac electrical devices and lead systems with pocket change and local flap coverage.
    Kolker AR; Redstone JS; Tutela JP
    Ann Plast Surg; 2007 Jul; 59(1):26-9; discussion 30. PubMed ID: 17589255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation.
    Wei S; Loyo-Berríos NI; Haigney MC; Cheng H; Pinnow EE; Mitchell KR; Beachy JH; Woodward AM; Wang Y; Curtis JP; Marinac-Dabic D
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):346-54. PubMed ID: 21487093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.
    Uslan DZ; Gleva MJ; Warren DK; Mela T; Chung MK; Gottipaty V; Borge R; Dan D; Shinn T; Mitchell K; Holcomb RG; Poole JE
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):81-7. PubMed ID: 22077194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.